{"id":"https://openalex.org/W1930097754","doi":"https://doi.org/10.1002/pds.3602","title":"The challenges of comparing results between placebo controlled randomized trials and non\u2010experimental new user, active comparator cohort studies: the example of olmesartan","display_name":"The challenges of comparing results between placebo controlled randomized trials and non\u2010experimental new user, active comparator cohort studies: the example of olmesartan","publication_year":2014,"publication_date":"2014-03-03","ids":{"openalex":"https://openalex.org/W1930097754","doi":"https://doi.org/10.1002/pds.3602","mag":"1930097754","pmid":"https://pubmed.ncbi.nlm.nih.gov/24590633","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4004366"},"language":"en","primary_location":{"id":"doi:10.1002/pds.3602","doi":"https://doi.org/10.1002/pds.3602","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pds.3602","pdf_url":null,"source":{"id":"https://openalex.org/S140231191","display_name":"Pharmacoepidemiology and Drug Safety","issn_l":"1053-8569","issn":["1053-8569","1099-1557"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and Drug Safety","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4004366","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035349303","display_name":"Wendy Camelo Castillo","orcid":"https://orcid.org/0000-0003-1336-8106","observed_orcids":["https://orcid.org/0000-0003-1336-8106"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I54713919","display_name":"Geisinger Health System","ror":"https://ror.org/02qdbgx97","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I54713919"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wendy Camelo Castillo","raw_affiliation_strings":["Center for Health Research; Geisinger Health System; Danville PA USA","Department of Environmental Health Sciences Johns Hopkins Bloomberg School of Public Health Baltimore MD USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Health Research; Geisinger Health System; Danville PA USA","institution_ids":["https://openalex.org/I54713919"]},{"raw_affiliation_string":"Department of Environmental Health Sciences Johns Hopkins Bloomberg School of Public Health Baltimore MD USA","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020253527","display_name":"Joseph A. Delaney","orcid":"https://orcid.org/0000-0003-1771-1776","observed_orcids":["https://orcid.org/0000-0003-1771-1776"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Joseph A. C. Delaney","raw_affiliation_strings":["Department of Epidemiology, University of Washington , Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Epidemiology, University of Washington , Seattle, WA, USA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043069598","display_name":"Til St\u00fcrmer\u200e","orcid":"https://orcid.org/0000-0002-9204-7177","observed_orcids":["https://orcid.org/0000-0002-9204-7177"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Til St\u00fcrmer","raw_affiliation_strings":["Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC USA","institution_ids":["https://openalex.org/I114027177"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5020253527"],"corresponding_institution_ids":["https://openalex.org/I201448701"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":0.3293,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":{"value":0.60916152,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"23","issue":"4","first_page":"357","last_page":"360"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.40939998626708984,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.40939998626708984,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10845","display_name":"Advanced Causal Inference Techniques","score":0.35519999265670776,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.04360000044107437,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/olmesartan","display_name":"olmesartan","score":0.9599999785423279},{"id":"https://openalex.org/keywords/antihypertensive-drugs","display_name":"antihypertensive drugs","score":0.7260000109672546},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.37700000405311584},{"id":"https://openalex.org/keywords/pharmacoepidemiology","display_name":"pharmacoepidemiology","score":0.6679999828338623}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7430445551872253},{"id":"https://openalex.org/C79581498","wikidata":"https://www.wikidata.org/wiki/Q1367530","display_name":"Suite","level":2,"score":0.6230664849281311},{"id":"https://openalex.org/C140556311","wikidata":"https://www.wikidata.org/wiki/Q214746","display_name":"Biostatistics","level":3,"score":0.5868574380874634},{"id":"https://openalex.org/C2779446402","wikidata":"https://www.wikidata.org/wiki/Q4036051","display_name":"Chapel","level":2,"score":0.5663036108016968},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.5523508191108704},{"id":"https://openalex.org/C161191863","wikidata":"https://www.wikidata.org/wiki/Q199655","display_name":"Library science","level":1,"score":0.540882408618927},{"id":"https://openalex.org/C107130276","wikidata":"https://www.wikidata.org/wiki/Q133805","display_name":"Epidemiology","level":2,"score":0.5224168300628662},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.38810813426971436},{"id":"https://openalex.org/C74909509","wikidata":"https://www.wikidata.org/wiki/Q10387","display_name":"Gerontology","level":1,"score":0.35194292664527893},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.13538292050361633},{"id":"https://openalex.org/C95457728","wikidata":"https://www.wikidata.org/wiki/Q309","display_name":"History","level":0,"score":0.09956130385398865},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.07780879735946655},{"id":"https://openalex.org/C166957645","wikidata":"https://www.wikidata.org/wiki/Q23498","display_name":"Archaeology","level":1,"score":0.06745398044586182},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C52119013","wikidata":"https://www.wikidata.org/wiki/Q50637","display_name":"Art history","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D003920","descriptor_name":"Diabetes Mellitus","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009203","descriptor_name":"Myocardial Infarction","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D013777","descriptor_name":"Tetrazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D013777","descriptor_name":"Tetrazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D057911","descriptor_name":"Angiotensin Receptor Antagonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D057911","descriptor_name":"Angiotensin Receptor Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.1002/pds.3602","doi":"https://doi.org/10.1002/pds.3602","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pds.3602","pdf_url":null,"source":{"id":"https://openalex.org/S140231191","display_name":"Pharmacoepidemiology and Drug Safety","issn_l":"1053-8569","issn":["1053-8569","1099-1557"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and Drug Safety","raw_type":"journal-article"},{"id":"pmid:24590633","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24590633","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and drug safety","raw_type":"Journal Article"},{"id":"pmh:oai:europepmc.org:3343416","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4004366","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4004366","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4004366","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Pharmacoepidemiol Drug Saf","raw_type":"Text"},{"id":"pmh:cdr.lib.unc.edu:pn89df46f","doi":null,"is_oa":true,"landing_page_url":"https://doi.org/10.17615/sb3y-zg88","pdf_url":"https://doi.org/10.17615/sb3y-zg88","source":{"id":"https://openalex.org/S4306401075","display_name":"Carolina Digital Repository (University of North Carolina at Chapel Hill)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I114027177","host_organization_name":"University of North Carolina at Chapel Hill","host_organization_lineage":["https://openalex.org/I114027177"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmacoepidemiology and Drug Safety, 23(4)","raw_type":"Article"},{"id":"doi:10.17615/sb3y-zg88","doi":"https://doi.org/10.17615/sb3y-zg88","is_oa":true,"landing_page_url":"https://doi.org/10.17615/sb3y-zg88","pdf_url":null,"source":{"id":"https://openalex.org/S7407051488","display_name":"UNC Libraries","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:3343416","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4004366","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1153751621","display_name":null,"funder_award_id":"R21-HL-120394","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G4770435777","display_name":"CVD and inflammation across the lifespan in HIV infected adults and children","funder_award_id":"5r21hl120394-02","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G5711986348","display_name":"A retrospective cohort study of the safety of testosterone therapy in older men","funder_award_id":"R01AG042845","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"},{"id":"https://openalex.org/G7441241992","display_name":"PROMIS Validation in Prospective Population-based Prostate Cancer Research Study","funder_award_id":"R01CA174453","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7616770747","display_name":null,"funder_award_id":"R21HL120394-01","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G8008223734","display_name":null,"funder_award_id":"AG023178","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"},{"id":"https://openalex.org/G8013340669","display_name":"Propensity Scores and Preventive Drug Use in the Elderly","funder_award_id":"R01AG023178","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"},{"id":"https://openalex.org/G9000092215","display_name":null,"funder_award_id":"R21HL120394-01","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320308927","display_name":"Patient-Centered Outcomes Research Institute","ror":"https://ror.org/014q65q44"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332177","display_name":"Agency for Healthcare Research and Quality","ror":"https://ror.org/03jmfdf59"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"},{"id":"https://openalex.org/F4320332600","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33"},{"id":"https://openalex.org/F4320333071","display_name":"UCB US","ror":"https://ror.org/028qka468"},{"id":"https://openalex.org/F4320337337","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11"},{"id":"https://openalex.org/F4320337338","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1930097754.pdf","grobid_xml":"https://content.openalex.org/works/W1930097754.grobid-xml"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W1498134033","https://openalex.org/W1891713006","https://openalex.org/W1967862917","https://openalex.org/W1969479683","https://openalex.org/W1988536563","https://openalex.org/W2015300603","https://openalex.org/W2037135054","https://openalex.org/W2047335781","https://openalex.org/W2061691003","https://openalex.org/W2108233388","https://openalex.org/W2119577709","https://openalex.org/W2135225222","https://openalex.org/W2144113585","https://openalex.org/W2168458505","https://openalex.org/W2169506520","https://openalex.org/W2475261460"],"related_works":["https://openalex.org/W4298304599","https://openalex.org/W4404685489","https://openalex.org/W2589233098","https://openalex.org/W2112646145","https://openalex.org/W4244243951","https://openalex.org/W2791065677","https://openalex.org/W6902158248","https://openalex.org/W2530539679","https://openalex.org/W6920781434","https://openalex.org/W3215404238"],"abstract_inverted_index":{"One":[0],"of":[1,4,15,53,57,65,100,111,142,175,179,189,203],"the":[2,13,22,38,54,58,66,97,104,109,145,150,176,187,204],"challenges":[3,155],"pharmacoepidemiology":[5],"that":[6,41,84,86],"is":[7,12,17,46,115,186,193],"both":[8],"exciting":[9],"and":[10,130,144,173],"frustrating":[11],"replication":[14],"findings.It":[16],"often":[18],"easy":[19],"to":[20],"frame":[21],"question":[23],"as":[24],"\"does":[25],"drug":[26],"X":[27],"cause":[28,118],"side":[29],"effect":[30,114],"Y\",":[31],"but":[32],"this":[33,63],"ignores":[34],"subtle":[35],"differences":[36],"in":[37,62,91,103,132,135],"actual":[39],"contrasts":[40],"are":[42,126,153,168],"being":[43],"made.This":[44],"issue":[45,64],"well":[47,128],"highlighted":[48],"by":[49,75],"three":[50,123],"recent":[51],"studies":[52,72,125],"cardiovascular":[55,199],"safety":[56,76],"medication":[59],"Olmesartan":[60,87],"published":[61],"Journal":[67],"1-3":[68],".These":[69],"non-experimental":[70,165],"(observational)":[71],"were":[73],"motivated":[74],"signals":[77],"from":[78,149],"two":[79,136],"randomized,":[80,159],"placebo":[81,160],"controlled":[82,161],"trials":[83,106],"suggested":[85],"increased":[88],"all-cause":[89],"mortality":[90],"patients":[92],"with":[93,156],"diabetes":[94],"[4][5]":[95],".Although":[96],"absolute":[98],"number":[99],"deaths":[101],"observed":[102],"randomized":[105],"was":[107],"small,":[108],"possibility":[110],"such":[112],"an":[113],"a":[116,158,164,194],"legitimate":[117],"for":[119,170,197],"concern":[120],"[1][2][3]":[121],".The":[122],"nonexperimental":[124],"all":[127],"designed":[129],"placed":[131],"independent":[133],"populations":[134],"different":[137],"countries":[138],"(the":[139],"United":[140,146],"States":[141],"America":[143],"Kingdom).However,":[147],"right":[148],"beginning,":[151],"there":[152],"intrinsic":[154],"replicating":[157],"trial":[162],"using":[163],"study":[166],"design.Drugs":[167],"given":[169],"specific":[171],"indications":[172,178],"one":[174],"primary":[177],"angiotensin":[180],"receptor":[181],"blockers":[182],"(ARBs),":[183],"including":[184],"Olmestartan,":[185],"treatment":[188],"hypertension.Unfortunately,":[190],"hypertension":[191],"itself":[192],"risk":[195],"factor":[196],"major":[198],"events.So":[200],"any":[201],"analysis":[202]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-06-24T00:00:00"}